Delivery Order SPE2DB20D2002-SPE2DB22FL28K
Award Date 3/25/22
Potential Completion Date 3/28/22
Potential Value $1.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen® 3mL, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $1,838.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 6, 2023. The contract has an ultimate completion date of April 7, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL medical devices to the Defense Logistics Agency (DLA). The $2,831.62 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Novolog® 100 unit/mL FlexPen® 3mL to the Defense Logistics Agency (DLA). The $1,426.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 23, 2025, with a completion date of January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The fixed-price delivery order, valued at $5,665.73, has an ultimate completion date of December 5, 2023. It was awarded on December 4, 2023, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
- This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,084.80 and is a firm fixed-price delivery order that runs through March 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of Novolog 100 Unit/mL FlexPen 3mL, a type of insulin medication, to the Defense Logistics Agency (DLA). The $1,361.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2022, with a performance completion date of June 27, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,035.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is not designated as a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,225.44 Firm Fixed Price delivery order contract is for the supply of NovologTM 100 unit/mL FlexPenTM 3mL, a medication used for diabetes management. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,110.67 and an ultimate completion date of November 9, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on November 8, 2023, and...